BEGIN:VCALENDAR METHOD:PUBLISH VERSION:2.0 CALSCALE:GREGORIAN PRODID:-//NONSGML WPForms//NONSGML Sugar Calendar Feeds v3.9.0//EN X-WR-CALNAME:27th Annual Scientific Meeting X-WR-CALDESC:Immunisation Coalition X-WR-TIMEZONE:Australia/Melbourne BEGIN:VTIMEZONE TZID:Australia/Melbourne BEGIN:DAYLIGHT TZOFFSETFROM:+1000 TZOFFSETTO:+1100 DTSTART:20251004T160000 TZNAME:AEDT END:DAYLIGHT END:VTIMEZONE BEGIN:VTIMEZONE TZID:Australia/Melbourne BEGIN:DAYLIGHT TZOFFSETFROM:+1000 TZOFFSETTO:+1100 DTSTART:20251004T160000 TZNAME:AEDT END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT SUMMARY:27th Annual Scientific Meeting DESCRIPTION:Watch the recordings\n\n\n\nIC Events\n\n\n\n\n\n\n\n\nStart : \;February 15\, 2026: 15:00:00 \;- \;Ends: \;February 16\, 2026: 16:00:00\n\n\n\nAbout\n\n\n\nThe 27th Annual Scientific Meeti ng will take place on Sunday\, February 15\, and Monday\, February 16\, 2026\, at the Pullman Melbourne Albert Park.\n\n\n\nThis event is expect ed to hold significant importance for the scientific and medical communi ty\, government health officials\, academics\, and various health-relate d non-government organizations.\n\n\n\nThis 2-day event is approved for 9 hours of CPD accreditation for online participants.\n\n\n\n\n\n\n\nAct ivity ID: \;1506493\n\n\n\n\nWatch the recordings\n\n\n\n\n***\n\n\n \nSUNDAY\n\n\n\n\n3:00 pmWelcome and Introduction▼\n\n\n\n\n\nhttps:// youtu.be/FRjW4KKLQ5Y\n\n\n\n\n\n\nSession 1\n\n\n\n\n3:10 pmThe Australi an CDC - an early days updateDr Stephanie Williams▼\n\nhttps://youtu.b e/ijpgdlLxpgg\n\n\n\n\nClick here for PPT slides\n\n\n\n\nDr Stephanie W illiams PSM is the Assistant Director-General in the Australian CDC. In this role\, she oversees the Communicable Diseases Branch responsible fo r Immunisation and vaccine-preventable diseases\, respiratory diseases\, sexually transmissible infections and bloodborne viruses and tuberculos is in the Australian CDC. \;Prior to this role\, Stephanie served as Australia’s Ambassador for Regional Health Security from March 2020 u ntil October 2023. As Ambassador\, Dr Williams supported the advancement of Australia’s interests in the Indo-Pacific by fostering linkages be tween Australia’s world-class public health and medical research exper ts and partners. In addition\, she guided the implementation of two majo r health initiatives: Partnerships for a Healthy Region ($620 million\, 2022-23 to 2026-27) and the $523 million regional Vaccine Access Initiat ive and was Australia’s Alternate Member on the Board of the Global Fu nd for HIV/AIDS\, TB and malaria. \;Dr Williams is a Public Health P hysician and Epidemiologist. She was the Principal Specialist Health at the Department for Foreign Affairs and Trade from 2017-2023 and previous ly served as a Medical Adviser to the Chief Medical Officer\, Public Hea lth Registrar for Victoria’s Chief Health Officer\; Epidemiologist in Global Health Security for the World Health Organization (WHO)\; and a m edical doctor for Medicines Sans Frontières and the WHO. Dr Williams ho lds a Bachelor of Medicine and Surgery from Monash University\, a Master of Public Health and Tropical Medicine from James Cook University\, and a Master of Applied Epidemiology from Australian National University (A NU). She is a Fellow of the Australasian Faculty of Public Health Medici ne.\n\n\n\n\n\n3:30 pmNIS 2025-30David Laffan▼\n\nhttps://youtu.be/qgB EGfSI1xc\n\n\n\n\nClick here for PPT slides\n\n\n\n\nDavid is the Assist ant Secretary\, Immunisation Access and Engagement Branch\, Department o f Health\, Disability and Ageing. He has almost 20 years’ experience a s a senior public servant in policy\, program and regulatory roles. As A ssistant Secretary for Immunisation he has responsibility for the Nation al Immunisation Strategy and its Implementation\, the Essential Vaccines Schedule\, Immunisation Programs for Priority Populations and is the Se nior Data Steward for the Australian Immunisation Register.\n\n\n\n\n\n3 :50 pmChanges in US vaccine policy - direction and impacts locally and a round the worldProf Stanley Perlman▼\n\n\n\n\n\nhttps://youtu.be/o5Hf8 yxI2UE\n\n\n\n\nClick here for PPT slides\n\n\n\n\nProfessor Perlman rec eived his Ph.D. in Biophysics from M.I.T.\, Cambridge\, Massachusetts an d his M.D. from the University of Miami\, Miami\, Florida. He is a membe r of the VRBPAC of the FDA\, the COVID-19 Advisory Committee of the ACIP (Advisory Committee on Immunization Practices) and WHO TAG-CO-VAC (Tech nical Advisory Group on COVID-19 Vaccine Composition).\n\n\n\nHis curren t research efforts are focused on coronavirus pathogenesis\, including v irus-induced demyelination and the Severe Acute Respiratory Syndrome (SA RS)\, the Middle East Respiratory Syndrome (MERS) and COVID-19. His labo ratory has developed several novel animal models useful for studying pat hogenesis and evaluating vaccines and antiviral therapies. His studies a re directed at understanding why aged patients and mice developed more s evere disease than younger individuals after infection with SARS-CoV or SARS-CoV-2 and also on why there is a male predominance in patients with more severe disease after infection with SARS-CoV\, MERS-CoV or SARS-Co V-2. He and his colleagues demonstrated that transduction of mice with a n adenovirus expressing the human receptor for MERS-CoV\, DPP4\, rendere d them sensitive to infection\, providing the first rodent model useful for studying MERS. Similar approaches have been used to develop several mouse models for COVID-19. Among other topics\, his research is now focu sing on the loss of sense of smell (anosmia) and taste (ageusia) observe d in patients with COVID-19. \;\n\n\n\n\n\n4:10 pmUSA vaccine polici es: impacts for Australia and the World Prof Kristine Macartney▼\n\n\n \n\n\nhttps://youtu.be/eX8TI3Jhl4Y\n\n\n\n\nClick here for PPT slides\n\ n\n\n\nProfessor Kristine Macartney is an infectious diseases paediatric ian specialising in vaccinology. She is a medical graduate of the Univer sity of New South Wales and undertook her specialty training in Sydney a nd in the United States at the Children’s Hospital of Philadelphia. He r Doctorate of Medicine was on rotavirus infection\, in particular the m ucosal immune response to novel vaccine candidates. She was a foundation al member of the Vaccine Education Center at the Children’s Hospital o f Philadelphia. Kristine is currently the Director of the Australian Nat ional Centre for Immunisation Research and Surveillance (NCIRS)\, a paed iatric infectious disease consultant at The Children’s Hospital at Wes tmead and a Professor in the Discipline of Paediatrics and Child Health\ , University of Sydney. Her research interests include translation of ev idence into policy and practice\, vaccine safety\, and most other areas of vaccine preventable diseases research\, particularly in relation to r otavirus\, varicella zoster virus and influenza. She is the senior edito r of the Australian Immunisation Handbook and has authored >\;290 peer -reviewed publications. She is a member of the Advisory Committee on Vac cines (ACV) of the Therapeutic Goods Administration (TGA)\, the Communic able Diseases Network of Australia (CDNA) and the Australian Technical A dvisory Group on Immunisation (ATAGI). She has acted as an expert consul tant to the World Health Organisation (WHO) and is a member of the WHO G lobal Advisory Committee on Vaccine Safety (GACVS) and WHO SAGE working groups. \; Kristine leads the Australian national AusVaxSafety and P aediatric Active Enhanced Disease Surveillance (PAEDS) networks\, and is the founding chair of the Australian Regional Immunisation Alliance (AR IA). She established and leads the NCIRS global team that has a program of work supporting >\;10 countries across the Asia Pacific region in i mmunisation system strengthening across a range of domains.\n\n\n\n\n\n4 :30 pmPanel discussion▼\n\n\n\n\n\n\n\n\n\n\n\n\nSession 2\n\n\n\n\n5: 10 pmThe latest on SARS-CoV-2: evolution and impactProf Allen Cheng▼\n \n\n\n\n\nhttps://youtu.be/6qJsQT7j3dA\n\n\n\n\nClick here for PPT slide s\n\n\n\n\nProf Allen Cheng is an infectious diseases physician. He is P rofessor of Infectious Diseases at Monash University and Program Directo r for Medical Specialties at Monash Health. He has previously been Co-Ch air of the Australian Technical Advisory Group on Immunisation\, Chair o f the Advisory Committee for Vaccines and was Deputy Victorian Chief Hea lth Officer in 2020-21.\n\n\n\n\n\n5:30 pmThe epidemiology and virology of influenza and bird fluProf Ian Barr▼\n\n\n\n\n\nhttps://youtu.be/Ir 83LzyROTA\n\n\n\n\nClick here for PPT slides\n\n\n\n\nProfessor Ian Barr is currently the Deputy Director of the WHO Collaborating Centre for Re ference and Research on Influenza (one of 5 globally) based at the Doher ty Institute in Melbourne\, Australia which has operated since 1992.&nbs p\; The Centre plays an active role in the regional surveillance of huma n influenza. Professor Barr has over 35 years’ experience in Research and Development both with academic and commercial groups including over 22 years at the Centre and has authored or co-authored nearly 300 public ations including over 250 peer reviewed journal articles\, reviews and e ditorials on various aspects of influenza. He holds an Honorary Professo rial position in the Department of Microbiology and Immunology at the Un iversity of Melbourne.\n\n\n\n\n\n5:50 pmNew risks and realities of meas les abroad and on Australian shoresProf Nigel McMillan▼\n\n\n\n\n\nhtt ps://youtu.be/rIfyE7ZvtGQ\n\n\n\n\nClick here for PPT slides\n\n\n\n\nPr ofessor McMillan is a Fellow of the Australasian Virology Society and a virologist whose research focuses on treatments for viruses and viral ca ncers. His early work explored novel RNA-based therapies for human papil lomavirus cancers\, later expanding to include Merkel cell cancers. He h as developed nanoparticle delivery systems for gene silencing and editin g therapies. His laboratory was the first to demonstrate that cancer cou ld be cured in vivo using CRISPR (2019)\, and that siRNAs could cure ani mals infected with COVID-19 (2021). His patents have been licensed to in ternational biotechnology companies\, and his team’s nanoparticle-deli vered gene silencing therapy for COVID-19 was recently licensed to The G ene Company for $135 million. Currently\, his lab is developing second-g eneration lipid nanoparticles inspired by natural particles such as extr acellular vesicles. Professor McMillan leads the Griffith Centre for Cel l and Gene Medicines\, which includes the Griffith Nanoparticle Biofound ry. He also serves as Professor in the School of Pharmacy and Medical Sc iences and Associate Director of the Institute for Biomedicine and Glyco mics at Griffith University. Committed to public engagement\, he has act ively contributed to discussions on infectious diseases\, gene therapy\, and vaccine issues\, conducting over 1\,200 media interviews during the COVID pandemic. He has also written for The Conversation and participat ed in public forums such as “After the pandemic: imagining the future with Kerry O’Brien.\n\n\n\n\n\n6:10 pmChildhood Immunisation: the p lan to get back to 95% coverageA/Prof Frank Beard▼\n\n\n\n\n\nhttps:// youtu.be/HdN1RXRuU_E\n\n\n\n\nClick here for PPT slides\n\n\n\n\nAssocia te Professor Frank Beard is the Associate Director at the National Centr e for Immunisation Research and Surveillance (NCIRS) in Sydney\, Austral ia. He has led the vaccine coverage\, vaccine-preventable disease survei llance\, program evaluation\, social science\, and Aboriginal and Torres Strait Islander immunisation teams for over a decade. He is also an Ass ociate Professor at the University of Sydney School of Public Health.\n\ n\n\nAssociate Professor Beard worked as a General Practitioner for 15 y ears before undertaking specialist training in public health medicine. H e then spent more than a decade working across health departments and pu blic health units in New South Wales and Queensland before joining NCIRS .\n\n\n\nHe has authored over 100 peer-reviewed journal articles and mor e than 30 major research reports for federal and state/territory governm ents and national bodies. His work primarily focuses on vaccine coverage \, vaccine-preventable disease epidemiology\, and immunisation program e valuation.\n\n\n\n\n\n6:40 pmPanel discussion▼\n\n\n\n\n\nhttps://yout u.be/u24-4aTHBN8\n\n\n\n\n\n\n\n\n\n\nSession 3\n\n\n\n\n7:40 pmVaccinat ing children in pharmacyBec Rogers▼\n\n\n\n\n\nhttps://youtu.be/0T990d tc0ag\n\n\n\n\nClick here for PPT slides\n\n\n\n\nBec Rogers is a regist ered pharmacist with over 20 years of experience across a broad range of roles within community pharmacy. She currently serves as Chief Pharmaci st at National Pharmacies\, where she leads a team of more than 200 phar macists\, driving a culture of innovation and excellence in patient care .\n\n\n\nPassionate about the evolving role of community pharmacy\, Bec is a dedicated advocate for preventative health. She champions the vital role pharmacists play in early intervention and improving health outcom es for patients.\n\n\n\nA respected and trusted voice in the pharmacy se ctor\, Bec brings extensive expertise in integrating pharmacy-led servic es—such as immunisation—into mainstream preventative healthcare in A ustralia\, reflecting her unwavering commitment to the profession and th e communities it serves.\n\n\n\n\n\n8:00 pmVaccines and Infectious Disea se Innovation: Bridging the Valley of DeathJennifer Herz▼\n\n\n\n\n\nh ttps://youtu.be/ZkwX26uw2HI\n\n\n\n\nClick here for PPT slides\n\n\n\n\n Jennifer Herz is the Co-Founder and Director of Biointelect\, a consulta ncy she established in 2012 to provide end-to-end commercialisation and strategy services to the biopharmaceutical sector\, leveraging over 30 y ears’ sector experience across Australia\, New Zealand\, and Europe. S he is also the Chief Investigator of the recently launched Biointelect V enturer – Australia’s national incubator for vaccine and infectious disease innovation\, funded by the Australian Government under the MRFF 2024 BioMedTech Incubator Grant Opportunity.\n\n\n\nEarlier in her caree r\, Jenny established Sanofi Pasteur as a major vaccine provider in Aust ralasia and was the founding Chair of the Medicines Australia Vaccine In dustry Group. She went on to senior leadership roles with AstraZeneca/Me dImmune in Europe\, contributing to international vaccine launches\, pol icy\, and market access strategies.\n\n\n\nJenny has extensive governanc e and policy experience\, including board and advisory roles with Medici nes Australia\, NASDAQ-listed biotech subsidiaries\, the NHMRC Health Re search Impact Committee\, the NSW Innovation and Productivity Council\, and the Australian AMR Network. Through these roles\, and her ongoing le adership at Biointelect and the BV Incubator\, she continues to shape th e future of vaccine innovation and commercialisation in Australia and gl obally.\n\n\n\n\n\n\nMONDAY\n\n\n\n\n9:00 amWelcome and Introduction▼\ n\n\n\n\n\n\n\n\n\n\n\n\nSession 4\n\n\n\n\n9:10 ammRNA platforms for CO VID\, Influenza and RSV vaccinesProf Tony Cunningham▼\n\n\n\n\n\nhttps ://youtu.be/V5k4gscsvvs\n\n\n\n\nClick here for PPT slides\n\n\n\n\nProf essor Tony Cunningham\, AO\, AAHMS\, MD\, FRACP\, FRCPA\, is an infectio us diseases physician\, clinical virologist and scientist\, internationa lly renowned for his research on the immunobiology of HIV and herpesviru ses\, his work on vaccine development and as an antiviral expert. He is Director of the Centre for Virus Research at The Westmead Institute for Medical Research\, Professor\, Faculty of Medicine and Health and Vaccin e Theme Leader\, Sydney Infectious Diseases Institute at the University of Sydney\, and Director of the Australian Centre for HIV and Hepatitis Virology Research (ACH4)\, a Commonwealth Government-funded institute th at aims to combat the impact of HIV and hepatitis in Australia and the A sia-Pacific region by bringing together basic researchers with translati onal scientists and physicians.\n\n\n\n\n\n9:30 amRSV prevention in infa nts: a model to build uponDr Daryl Cheng▼\n\n\n\n\n\nhttps://youtu.be/ n-lGi8N9L2w\n\n\n\n\nClick here for PPT slides\n\n\n\n\nAssociate Profes sor Daryl Cheng is a Consultant Paediatrician\, Digital Health Consultan t\, and Clinical Informatician at The Royal Children’s Hospital Melbou rne (RCH)\, and Head of Paediatrics at Cabrini Health. He also holds aca demic appointments as an Honorary Clinical Research Fellow at the Murdoc h Children’s Research Institute (MCRI) and an Honorary Principal Fello w in the Department of Paediatrics\, University of Melbourne.\n\n\n\nHe is actively involved in systems thinking\, innovation\, and design throu gh his appointments at RCH within the Melbourne Children’s Campus Cent re for Health Analytics (CHA) and the RCH Digital Innovation &\; EMR Team. Associate Professor Cheng has a strong interest in public health a nd policy\, reflected in his previous roles with Safer Care Victoria\, S urveillance of Adverse Events Following Vaccination in the Community (SA EFVIC)\, and the Melbourne Vaccine Education Centre (MVEC).\n\n\n\n\n\n9 :50 amRSV prevention in older adultsProf Paul Griffin▼\n\n\n\n\n\nhttp s://youtu.be/Jj57jG5n478\n\n\n\n\nClick here for PPT slides\n\n\n\n\nPau l is an accomplished clinical trial investigator\, having fulfilled the role of Principal Investigator in over 150 clinical trials\, particularl y in Infectious Diseases including 8 COVID-19 vaccines.\n\n\n\nDespite a n already demanding role at the Mater\, Paul continues as a member of th e AMA Queensland Council 2023-2024\, and as board member and scientific advisory board member of the Immunisation Coalition\, with active intere st in vaccine education and advocacy\, becoming a trusted media authorit y and spokesperson across the nation during the COVID-19 pandemic.\n\n\n \n\n\n10:10 am Panel discussion▼\n\n\n\n\n\nhttps://youtu.be/ooAU6bSGe DI\n\n\n\n\n\n\n\n\n\n\nSession 5\n\n\n\n\n10:50 amBeyond vaccinating ag ainst specific diseases: prevention benefits of other diseasesProf Micha el Woodward▼\n\n\n\n\n\nhttps://youtu.be/qOG3wI6XOKc\n\n\n\n\nClick he re for PPT slides\n\n\n\n\nAssociate Professor Michael Woodward is Head of Aged Care Research at Austin Health in Melbourne\, Victoria. He is a specialist in geriatric medicine with a major interest in adult vaccinat ion and also Alzheimer’s disease and other dementias\, wound managemen t and the quality use of medications in older people. He is head of the Medical and Cognitive Research Unit that conducts trials into new vaccin es and other new therapies for conditions such as dementia and influenza .\n\n\n\nAssociate Professor Woodward’s publication record includes ov er 130 peer-reviewed research and review articles. As chair of the Geria tric Therapeutics section of the editorial board of the Journal of Pharm acy Practice and Research he oversaw nearly 20 years of publications on quality use of medications and health promotion activities in older peop le\, including articles on vaccination. \; He was also joint editor of Wound Practice and Research\, the journal of the Australian Wound Man agement Association\, of which he is a past President. He is a member of the editorial committee of the Department of Veteran’s Affairs MATES program\, which improves prescribing and pharmaceutical care of DVA bene ficiaries\, including vaccination.\n\n\n\nHe is heavily involved in a nu mber of professional organizations including previously Chairing the Com mittee for Physician Training\, Royal Australasian College of Physicians \, which oversaw and approved the training of all future consultants in internal medicine. He is currently Chair of that College’s Site Accred itation Committee and was previously a member of their Board of Censors. He was until recently a member of the Geriatric Medicine Education and Training Subcommittee of the Australian and New Zealand Society for Geri atric Medicine\, having previously chaired that subcommittee. He has rec ently overseen a 3rd revision of that Society’s position document on V accinations for Older People.\n\n\n\nHis work in geriatric medicine\, de mentia and other research and his extensive authorship has been honoured with Membership of the Order of Australia\, awarded on Australia Day 20 16.\n\n\n\n\n\n11:10 amTravel vaccination: latest information and advice for international travelDr Sarah McGuinness▼\n\n\n\n\n\nhttps://youtu .be/oaFAB6mEP_s\n\n\n\n\nClick here for PPT slides\n\n\n\n\nDr Sarah McG uinness is an infectious diseases physician at Alfred Health and Monash University in Melbourne\, with a special interest in travel and tropical medicine. She leads the hospital-based travel clinic at the Alfred Hosp ital. Sarah is a member of ATAGI\, an Associate Editor of the Journal of Travel Medicine\, co-hosts the ISTM Travel Unravelled podcast\, and co- facilitates an annual Travel Medicine Masterclass for Australian provide rs. She has authored more than 50 peer-reviewed publications and book ch apters on travel medicine and vaccine-preventable diseases.\n\n\n\n\n\n1 1:30 amTuberculosis: An old foe in a modern world - advances\, challenge s and the path forwardProf Jamie Triccas▼\n\n\n\n\n\nhttps://youtu.be/ T6r3KB_S268\n\n\n\n\nClick here for PPT slides\n\n\n\n\nProfessor Jamie Triccas is a bacteriologist who uses a multidisciplinary approach to def ine immunity to chronic bacterial pathogens and develop new treatments t o control infection. He is a Professor of Medical Microbiology and Deput y Director of the Sydney Institute Infectious Diseases (Sydney ID) at th e University of Sydney. He has over 30 years’ experience working with clinically important pathogens and has published widely on aspects of ba cterial pathogenesis\, immunity to infection and vaccine development/tes ting. His team has progressed multiple vaccine candidates from discovery through to preclinical readiness\, including a CEPI-funded broadly prot ective coronavirus vaccine that will soon enter clinical trials. He prov ides scientific and program leadership across national and international collaborations involving academia\, industry and global health organisa tions\, helping to build Australia’s capability in translational vacci ne research and infectious disease preparedness.\n\n\n\n\n\n11:50 amPane l discussion▼\n\n\n\n\n\nhttps://youtu.be/nBr6ZDoS6-g\n\n\n\n\n\n\n\n\ n\n\nSession 6\n\n\n\n\n1:10 pmEvolving epidemiology of JEV and MVE in A ustralia: environmental drivers\, risk mapping\, and vaccination strateg iesProf Colleen Lau▼\n\n\n\n\n\nhttps://youtu.be/1EAAAJykHbk\n\n\n\n\n Click here for PPT slides\n\n\n\n\nProfessor Colleen Lau is an NHMRC Fel low and Professorial Research Fellow at the UQ Centre for Clinical Resea rch. Her areas of expertise include emerging infectious diseases\, negle cted tropical diseases\, and clinical travel medicine. Her wide range of research interests encompass infectious disease epidemiology\, spatial epidemiology and disease mapping\, infectious disease surveillance and e limination\, vaccinations\, travel health\, environmental health\, and d igital decision support tools. Professor Lau’s research projects focus on answering practical questions in clinical management of infectious d iseases and operational questions on improving strategies to solve publi c health problems. She leads UQ's HERA program on Operational Research a nd Decision Support for Infectious Diseases (ODeSI).\n\n\n\n\n\n1:30 pmP neumococcal disease in children: impact on recent changes to the NIPDr S anjay Jayasinghe▼\n\n\n\n\n\nhttps://youtu.be/5RXKNTWftfo\n\n\n\n\nCli ck here for PPT slides\n\n\n\n\nSanjay is a medical graduate with postgr aduate qualifications in community medicine and public health. He is an epidemiologist/research fellow in the National Centre for Immunisation R esearch and Surveillance (NCIRS). Sanjay holds a conjoint academic appoi ntment as Senior Lecturer in Children’s Hospital Westmead Clinical Sch ool of The University of Sydney. His PhD from University of Sydney was o n effectiveness of pneumococcal vaccinations in Australian children and epidemiology of pneumococcal disease in special risk groups. Sanjay’s work at NCIRS for over 10 years has primarily been in evidence-based tec hnical support for development of immunisation policy and practice in Au stralia. He holds a NHMRC emerging leader fellowship. In addition to inf ectious disease epidemiology\, he also has extensive experience as a hea lth services researcher in the areas of quality and safety of healthcare for the elderly\, evaluation of complex system interventions\, and asse ssment of provider and consumer perspectives of healthcare.\n\n\n\n\n\n1 :50 pmPneumococcal disease in adults: current challenges and future vacc ines Prof Paul van Buynder▼\n\n\n\n\n\nhttps://youtu.be/6dVZLyk2Qes\n\ n\n\n\nClick here for PPT slides\n\n\n\n\nProf Paul Van Buynder is a Pub lic Health Physician and past Chairman of the Immunisation Coalition. He is a professor in the School of Medicine at Griffith University in Quee nsland. He has held senior public health positions in a number of Austra lian states\, in two Canadian jurisdictions and at the Centre for Infect ions in the UK. He has held personal appointments on sub-committees of N ational Immunisation Technical Advisory Committees in three continents. Paul is a reviewer of over 10 journals and has over 80 referred book cha pters and articles.\n\n\n\n\n\n2:10 pmPanel discussion▼\n\n\n\n\n\nhtt ps://youtu.be/G7nBh_UY08g\n\n\n\n\n\n\n\n\n\n\nSession 7\n\n\n\n\n2:50 p mPertussis is back: what more should we do?Dr Andrew Baird▼\n\n\n\n\n\ nhttps://youtu.be/0j2L3dKlBJg\n\n\n\n\nClick here for PPT slides\n\n\n\n \nAndrew is a General Practitioner in St Kilda\, Melbourne\, and a Medic al Advisor with a medical defence organisation. \; He has a backgrou nd in rural general practice and medical education.\n\n\n\n\n\n3:10 pmHP V vaccination is slipping: strategies to protect teenagersProf Julia Bro therton▼\n\n\n\n\n\nhttps://youtu.be/GIEXKdk9VUo\n\n\n\n\nClick here f or PPT slides\n\n\n\n\nProfessor Julia Brotherton is a Professor of Canc er Prevention Policy and Implementation\, Melbourne School of Population and Global Health at The University of Melbourne and a Professorial Fel low at the National Centre for Immunisation Research and Surveillance. S he is a public health physician and epidemiologist\, who has worked in c ervical screening and human papillomavirus (HPV) vaccination since 2004 and has an international reputation in HPV vaccination and cervical canc er prevention research\, policy and practice\, as evidenced by appointme nts to the WHO Director General’s Expert Advisory Group on Cervical Ca ncer Elimination\, the International Agency for Research on Cancer (IARC ) Working Group for Handbook 18 on Cervical Screening\, and as Co-Chair of the CHIC global HPV Vaccine Council. She is a chief investigator in t he NHMRC Centre of Research Excellence in Cervical Cancer Control and ho lds an NHMRC Leadership Fellowship evaluating single dose HPV vaccinatio n in Australia. Her current work is focused on achieving equity in the d elivery and outcomes of strategies for scale up to support the WHO call to eliminate cervical cancer as a public health problem.\n\n\n\n\n\n3:30 pmVaccine safety- using real world data in a rapidly changing worldProf Jim Buttery▼\n\n\n\n\n\nhttps://youtu.be/4DuNNn4wnAo\n\n\n\n\nClick h ere for PPT slides\n\n\n\n\nJim Buttery is the inaugural Professor of Ch ild Health Informatics at the University of Melbourne based at the Melbo urne Children’s Campus Centre for Health Analytics. He is the Chief Re search Information Officer and an infectious diseases physician at the R oyal Children’s Hospital\, Melbourne. He is also the Head of Epidemiol ogy and Signal Detection of SAEFVIC\, the Victorian Immunisation Safety Service\, and Head of the Epidemiology Informatics Research Group\, at t he Murdoch Children’s Research Institute\, and the co-director of the Global Vaccine Data Network. Jim leads an epi-informatics team of epidem iologists\, data analysts and statisticians whose research revolves arou nd innovative use of real-world data to answer important questions in in fectious diseases epidemiology\, vaccine safety and effectiveness.\n\n\n \nThese innovations include Introducing Australia’s first state based public facing vaccine safety report\, updated weekly\, to inform the pub lic and maintain vaccine confidence (Saefvic.online/vaccinesafety)\, dev elopment of syndromic vaccine safety surveillance methodologies\, includ ing de-identified telephone help line and GP data network surveillance w hich have been incorporated into DHHS Victoria surveillance\, and the es tablishment of the Vaccine Safety Health Link (VSHL). VSHL is a statewid e Victorian prospective vaccine safety datalinkage project linking Victo rian Australian immunisation Register data to hospital admissions\, emer gency presentations\, perinatal\, births and deaths and primary care dat asets. This is the only vaccine datalink system in Australia incorporati ng perinatal and GP data.\n\n\n\nTo understand the full impact of common viruses upon human health\, he has established Snotwatch\, a novel popu lation wide spatiotemporal platform to link viral exposures to health ou tcomes\, and understand the full health and economic burden of these vir uses. Initial studies have shown new associations with febrile seizures\ , Kawasaki Disease\, childhood hepatitis and chilblains. Using pathology \, environmental exposures\, and hospital\, ED and GP datasets\, we are generating new insights into common respiratory viruses.\n\n\n\n\n\n\nSu mmary and Closing Comments\n\n\n\n\n3:50 pmFrom the Chair▼\n\n\n\n\n\n https://youtu.be/zuE69qoHGn0\n\n\n\n\n\n\n\n\n\n\n\nWatch the recordings \n\n\n\nDownload the Program\n\n\n\n\n\nSponsors URL;VALUE=URI:https://immunisationcoalition.org.au/events/27th-annual-sc ientific-meeting/ UID:urn:uuid:04fee872-e73a-4563-a4fc-dfb53c1291ff STATUS:CONFIRMED ORGANIZER: DTSTAMP:20260315T200822Z DTSTART;TZID=Australia/Melbourne:20260215T150000 DTEND;TZID=Australia/Melbourne:20260216T160000 END:VEVENT END:VCALENDAR